APTIV PLC (APTV)
Sector: Consumer Discretionary
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Consumer Discretionary
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for APTV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| APTV | Lead Independent Director | 73 | ["Extensive public company experience as both an executive and a board member","Expertise in management, strategy, finance and capital markets, operations, and mergers and acquisitions"] | ["Compensation and Human Resources Committee","Finance Committee","Nominating and Governance Committee","Audit","Finance","Compensation"] | 2026 |
Companies shown below are based on exact name match for the selected Director
Biography sourced from the proxy statement filing.
Paul M. Meister has been a director since July 2019 and our Lead Independent Director since April 2022. Mr. Meister is a partner in Novalis LifeSciences, a Life Science focused venture firm and is also co-founder and Chief Executive Officer of Liberty Lane Partners, LLC, a private investment company with investment holdings in healthcare, technology and distribution-related industries. From 2014 to 2018, he was President of MacAndrews & Forbes Incorporated, a private company that owns or controls a diverse set of businesses. During 2018, he also served, on an interim basis, as Executive Vice Chairman of Revlon, Inc. a leading beauty products company. He served from 2010 to 2014 as Chairman and Chief Executive Officer of inVentiv Health (now Syneos Health), a leading provider of commercial, consulting and clinical research services to the pharmaceutical and biotech industries. He was Chairman of Thermo Fisher Scientific Inc, a scientific instruments equipment and supplies company, from November 2006 to April 2007. He was previously an Executive Officer of Fisher Scientific International Inc., a predecessor of Thermo Fisher Scientific from 1991 to 2006. Mr. Meister has a bachelor s degree from the University of Michigan and a master s of business administration degree from Northwestern University. QUALIFICATIONS: Mr. Meister s extensive public company experience, as both an executive and a board member, provides the Board with significant expertise in management, strategy, finance and capital markets, operations, and mergers and acquisitions. LEAD INDEPENDENT DIRECTOR DIRECTOR SINCE: JULY 2019 APTIV COMMITTEE MEMBERSHIPS: Compensation and Human Resources Committee, Finance Committee and Nominating and Governance Committee (Chair) Current Public Company Directorships: Amneal Pharmaceuticals, Inc. (Non-Executive Chair) Oaktree Acquisition Corp.III Life Sciences Previous Public Company Directorships in Last Five Years: Oaktree Acquisition Corp.I (2019-2021) Oaktree Acquisition Corp.II (2020-2022) Quanterix Corporation (2013-2025)